Regulatory And Cost Implications For Switching Injectable Delivery Formats

Since there are various options for injectable formats, it’s not an uncommon practice to launch a large molecule in one format and then later decide to switch the delivery format. This common practice often transpires as a lifecycle management strategy that not only provides cost-effective solutions and supply chain continuity, but also provides patient benefits.

In this webinar, hear industry expert, Christy Eatmon, discuss:

• Evaluating regulatory and cost implications
• Trends for switching
• Release profile options
• Supply chain requirements and lead times